ENGAGE run · 5e69a850a62b

```json [ { "post_index": 0, "cluster_ids": [8, 14], "claim": "AI cannot yet automate insurance claim pricing and settlement decisions", "argument_type": "empirical_claim", "stance": "neutral_analysis", "hyde_excerpt": "Senior insurance executives remain skeptical that artificial intelligence has reached a level of maturity sufficient to automate core underwriting and cla

```json [ { "post_index": 19, "matched_article_id": 497, "match_confidence": 84, "match_reason": "Tweet argues that GLP-1 muscle loss claims need engagement with primary literature (Lundgren et al. 2021) to be valid, directly mapping to the article's thesis that the GLP-1 molecule itself is a commoditizing asset and that durable value lies in clinical evidence estates and adheren

The Lundgren framing is useful but it can cut both ways. Treating one study as a credentialing threshold risks the same epistemic shortcut you're warning against, just inverted. Primary literature engagement matters, but so does which primary literature. The harder version of this problem (and the one I keep running into when writing about GLP-1 economics) is that the muscle loss debate is downst

The self-selection argument is real, but the payment mechanics are about to scramble it further. Nephrology is already one of the most Medicare-dependent specialties in medicine, which means the conversion factor cuts hitting $32.35 in 2025 (down from $33.29 in 2024, with a two-track QAP/non-QP split coming in 2026) land harder there than almost anywhere. The intellectual complexity stays constan

```json [ { "post_index": 2, "cluster_ids": [7, 20], "claim": "COVID fraud detection infrastructure gutted, reversing creates tech opportunity", "argument_type": "policy_argument", "stance": "challenges_status_quo", "hyde_excerpt": "The rapid disbursement of COVID relief funds required temporary suspension of fraud detection infrastructure across federal healthcare and so

```json [ { "post_index": 1, "matched_article_id": 28, "match_confidence": 85, "match_reason": "The DOJ FOCUS initiative explicitly calls for 'data-driven whistleblowers' with 'sophisticated statistical methodologies' to detect fraud across federal programs — the article argues specifically that linking public datasets (NPPES, OIG exclusion lists, Medicaid spend data) creates a v

The $2.80 return per $1 spent on HCFAC enforcement already proves the economics work. The methodology gap isn't sophistication, it's linkage. The fraud signatures that actually hold up, new LLC formation date combined with billing escalation to the 95th percentile within 18 months, authorized officials appearing across multiple NPI registrations, ramp-and-exit temporal patterns, none of that requ

```json [ { "post_index": 0, "prediction": "approve", "confidence": 76, "reason": "Direct match to healthcare fraud detection systems. Post announces DOJ data-driven fraud initiative with statistical rigor—aligns with article on linking datasets to catch healthcare fraud. Substanti

```json [ { "category": "ai_safety_cybersecurity_incident_tangential", "summary": "Posts about AI model security vulnerabilities, data breaches, or safety incidents without direct healthcare application context.", "exclusion_rule": "Exclude posts that report AI safety vulnerabilities,